Transgenic Expression of Helicobacter Pylori CagA Induces Gastrointestinal and Hematopoietic Neoplasms in Mouse

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2008 Jan 15

PMID 18192401

Citations 288

Authors

Naomi Ohnishi

Hitomi Yuasa

Shinya Tanaka

Hirofumi Sawa

Motohiro Miura

Atsushi Matsui

Hideaki Higashi

Manabu Musashi

Kazuya Iwabuchi

Misao Suzuki

Gen Yamada

Takeshi Azuma

Masanori Hatakeyama

Affiliations

Soon will be listed here.

Abstract

Infection with cagA-positive Helicobacter pylori is associated with gastric adenocarcinoma and gastric mucosa-associated lymphoid tissue (MALT) lymphoma of B cell origin. The cagA-encoded CagA protein is delivered into gastric epithelial cells via the bacterial type IV secretion system and, upon tyrosine phosphorylation by Src family kinases, specifically binds to and aberrantly activates SHP-2 tyrosine phosphatase, a bona fide oncoprotein in human malignancies. CagA also elicits junctional and polarity defects in epithelial cells by interacting with and inhibiting partitioning-defective 1 (PAR1)/microtubule affinity-regulating kinase (MARK) independently of CagA tyrosine phosphorylation. Despite these CagA activities that contribute to neoplastic transformation, a causal link between CagA and in vivo oncogenesis remains unknown. Here, we generated transgenic mice expressing wild-type or phosphorylation-resistant CagA throughout the body or predominantly in the stomach. Wild-type CagA transgenic mice showed gastric epithelial hyperplasia and some of the mice developed gastric polyps and adenocarcinomas of the stomach and small intestine. Systemic expression of wild-type CagA further induced leukocytosis with IL-3/GM-CSF hypersensitivity and some mice developed myeloid leukemias and B cell lymphomas, the hematological malignancies also caused by gain-of-function SHP-2 mutations. Such pathological abnormalities were not observed in transgenic mice expressing phosphorylation-resistant CagA. These results provide first direct evidence for the role of CagA as a bacterium-derived oncoprotein (bacterial oncoprotein) that acts in mammals and further indicate the importance of CagA tyrosine phosphorylation, which enables CagA to deregulate SHP-2, in the development of H. pylori-associated neoplasms.

Citing Articles

Complex Roles of /SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy.

Scheiter A, Lu L, Gao L, Feng G Annu Rev Cancer Biol. 2025; 8(1):15-33.

PMID: 39959686 PMC: 11824402. DOI: 10.1146/annurev-cancerbio-062722-013740.

The Influence of Gastric Microbiota and Probiotics in Infection and Associated Diseases.

Verma J, Anwar M, Linz B, Backert S, Pachathundikandi S Biomedicines. 2025; 13(1).

PMID: 39857645 PMC: 11761556. DOI: 10.3390/biomedicines13010061.

How Do Trematodes Induce Cancer? A Possible Evolutionary Adaptation of an Oncogenic Agent Transmitted by Flukes.

Apari P, Foldvari G Evol Appl. 2025; 18(1):e70070.

PMID: 39845579 PMC: 11751881. DOI: 10.1111/eva.70070.

A unique strain to study gastric cancer development.

Whitmire J, Windham I, Makobongo M, Westland M, Tran S, Pinol J Microbiol Spectr. 2024; 13(1):e0216324.

PMID: 39641575 PMC: 11705839. DOI: 10.1128/spectrum.02163-24.

infection and oxidative stress.

Suzuki H, Hirai M J Clin Biochem Nutr. 2024; 75(3):178-182.

PMID: 39583977 PMC: 11579850. DOI: 10.3164/jcbn.24-109.

References

Segal E, Cha J, Lo J, Falkow S, Tompkins L . Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A. 1999; 96(25):14559-64. PMC: 24475. DOI: 10.1073/pnas.96.25.14559. View

Rieder G, Merchant J, Haas R . Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology. 2005; 128(5):1229-42. DOI: 10.1053/j.gastro.2005.02.064. View

Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M . SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2001; 295(5555):683-6. DOI: 10.1126/science.1067147. View

Selbach M, Moese S, Hauck C, Meyer T, Backert S . Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem. 2002; 277(9):6775-8. DOI: 10.1074/jbc.C100754200. View

Peek Jr R, Blaser M . Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002; 2(1):28-37. DOI: 10.1038/nrc703. View

Parkin D . Global cancer statistics in the year 2000. Lancet Oncol. 2002; 2(9):533-43. DOI: 10.1016/S1470-2045(01)00486-7. View

Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T . Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002; 99(22):14428-33. PMC: 137900. DOI: 10.1073/pnas.222375399. View

Mimuro H, Suzuki T, Tanaka J, Asahi M, Haas R, Sasakawa C . Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol Cell. 2002; 10(4):745-55. DOI: 10.1016/s1097-2765(02)00681-0. View

Churin Y, Al-Ghoul L, Kepp O, Meyer T, Birchmeier W, Naumann M . Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol. 2003; 161(2):249-55. PMC: 2172921. DOI: 10.1083/jcb.200208039. View

10.

Humbert P, Russell S, Richardson H . Dlg, Scribble and Lgl in cell polarity, cell proliferation and cancer. Bioessays. 2003; 25(6):542-53. DOI: 10.1002/bies.10286. View

11.

Tartaglia M, Niemeyer C, Fragale A, Song X, Buechner J, Jung A . Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003; 34(2):148-50. DOI: 10.1038/ng1156. View

12.

Higashi H, Nakaya A, Tsutsumi R, Yokoyama K, Fujii Y, Ishikawa S . Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J Biol Chem. 2004; 279(17):17205-16. DOI: 10.1074/jbc.M309964200. View

13.

Araki T, Mohi M, Ismat F, Bronson R, Williams I, Kutok J . Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med. 2004; 10(8):849-57. DOI: 10.1038/nm1084. View

14.

Schubbert S, Lieuw K, Rowe S, Lee C, Li X, Loh M . Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood. 2005; 106(1):311-7. PMC: 1895116. DOI: 10.1182/blood-2004-11-4207. View

15.

Tartaglia M, Gelb B . Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet. 2005; 48(2):81-96. DOI: 10.1016/j.ejmg.2005.03.001. View

16.

Suzuki M, Mimuro H, Suzuki T, Park M, Yamamoto T, Sasakawa C . Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J Exp Med. 2005; 202(9):1235-47. PMC: 2213224. DOI: 10.1084/jem.20051027. View

17.

Tsutsumi R, Takahashi A, Azuma T, Higashi H, Hatakeyama M . Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol. 2005; 26(1):261-76. PMC: 1317644. DOI: 10.1128/MCB.26.1.261-276.2006. View

18.

Naito M, Yamazaki T, Tsutsumi R, Higashi H, Onoe K, Yamazaki S . Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology. 2006; 130(4):1181-90. DOI: 10.1053/j.gastro.2005.12.038. View

19.

Alessi D, Sakamoto K, Bayascas J . LKB1-dependent signaling pathways. Annu Rev Biochem. 2006; 75:137-63. DOI: 10.1146/annurev.biochem.75.103004.142702. View

20.

Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y . Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007; 447(7142):330-3. DOI: 10.1038/nature05765. View